MOA Life Plus
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
MOA Life Plus develops biopharmaceutical drug candidates and makes health supplements and skincare products built around a natural polymer ingredient called poly-gamma-glutamic acid (γ-PGA).
Its consumer products reach both individual shoppers and business customers, while a separate division distributes prescription drugs, over-the-counter medicines, and medical supplies through specialist wholesalers. Listed on KOSDAQ, Korea's tech and small-cap board, the company runs three distinct lines, drug development, consumer goods, and pharmaceutical distribution, under one roof.
Summary is AI-generated and may contain errors · figures from DART filings
The company holds its γ-PGA ingredient approved as a functional raw material by Korea's Ministry of Food and Drug Safety, and separately cleared as a New Dietary Ingredient by the US FDA, enabling overseas market entry.
MOA Life Plus in five facts
What does MOA Life Plus do?
MOA Life Plus develops biopharmaceutical drug candidates and makes health supplements and skincare products built around a natural polymer ingredient called poly-gamma-glutamic acid (γ-PGA).
Where is MOA Life Plus listed and in which sector?
MOA Life Plus (Korean name: 모아라이프플러스) trades under KRX code 142760 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Industrials sector, Commercial Services.
How large is MOA Life Plus?
Its market capitalisation was US$8.2M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were MOA Life Plus's latest annual revenue and operating profit?
For fiscal year 2025, MOA Life Plus reported revenue of US$8.5M, an operating loss of US$4.9M and a net loss of US$9.9M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was down 28.2% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- [Amended] Material event reportOct 21
- [Amended] Material event reportOct 20
- [Amended] Small public offering disclosure (equity)Oct 19
- [Amended] Material event report (rights offering)
MOA Life Plus updated the terms of a private placement (third-party allotment) to raise US$1.5M, about 18.2% of its market value.
Capital raise · Oct 19 · 8 versions - [Amended] Material event report (convertible bonds)
MOA Life Plus updated the terms of convertible bonds to raise US$3.72M, about 49.4% of its market value.
Capital raise · Oct 16 · 6 versions - [Amended] Share-pledge agreement that may change the largest shareholder
MOA Life Plus's largest shareholder (Moadata) pledged shares as loan collateral, securing up to US$4.33M.
Ownership change · Oct 15 · 10 versions - Report on large shareholdings (5% rule) (standard)Oct 15
- [Amended] Small public offering disclosure (equity)Oct 14
- [Amended] Resolution to convene a general shareholders' meeting (extraordinary meeting)Oct 13
- [Amended] Resolution to convene a general shareholders' meeting (extraordinary meeting)Oct 13
- [Amended] Proxy solicitation reference documentOct 13
- [Amended] Notice of general shareholders' meetingOct 13
- [Amended] Early redemption of convertible bonds (incl. overseas CBs)Capital raise · Oct 12
- DisclosureOct 12
- Other market noticeOct 12
- [Amended] Small public offering disclosure (equity)Oct 12
- Report on large shareholdings (5% rule) (abbreviated)Oct 12
- [Amended] Early redemption of convertible bonds (incl. overseas CBs)Capital raise · Oct 8 · 2 versions
- Report on large shareholdings (5% rule) (standard)Oct 1
- [Amended] Proxy solicitation reference documentSep 29
- [Amended] Notice of general shareholders' meetingSep 29
- Material event report (rights offering)
MOA Life Plus disclosed a private placement (third-party allotment) to raise US$2.96M, about 39.4% of its market value.
Capital raise · Sep 29 - [Amended] Resolution to convene a general shareholders' meeting (extraordinary meeting)Sep 28
- [Amended] Small public offering disclosure (equity)Sep 28
- Report on large shareholdings (5% rule) (abbreviated)Sep 22
- [Amended] Resolution to convene a general shareholders' meeting (extraordinary meeting)Sep 21
- Proxy solicitation reference documentSep 21
- Notice of general shareholders' meetingSep 21
- [Amended] Small public offering disclosure (equity)Sep 21
- Small public offering disclosure (equity)Sep 16
- [Amended] Resolution to convene a general shareholders' meeting (extraordinary meeting)Sep 15
- Conversion price adjustmentSep 14
- Report on securities held by executives/major shareholdersSep 2
- Report on large shareholdings (5% rule) (standard)Sep 2
- Report on securities held by executives/major shareholdersSep 2
- [Attachment amended] Material event report (convertible bonds)Capital raise · Aug 18
- Trading suspension (share consolidation/split registration)
Trading in MOA Life Plus Co., Ltd. common shares will be suspended from August 7, 2026 until the day before the new share certificates' listing date, due to a share consolidation requiring a change in electronic registration.
M&A · Aug 4 - Early redemption of convertible bonds (incl. overseas CBs)
MOA Life Plus acquired US$555K in face value of its 11th-series convertible bonds before maturity on 2026-07-29 following exercise of a put option, paying US$625K (principal plus interest) and reducing the outstanding face value to US$184K; the acquired bonds will be retired.
Capital raise · Jul 29 - [Attachment amended] Material event report (convertible bonds)Capital raise · Jul 15
- Early redemption of convertible bonds (incl. overseas CBs)Capital raise · Jul 1